FATTY ACID SYNTHASE INHIBITOR FOR USE IN THE TREATMENT OF DRUG RESISTANT CANCER

摘要

A compound that is a fatty acid synthesis regulator is provided. Such compounds may be used in pharmaceutical compositions to treat taxane-resistant cancers. The method is provided for treating taxane-resistant cancer in a subject. The method is also provided to increase the sensitivity of cancer cells to the treatment of taxanes (i.e., paclitaxel, Nab-paclitaxel docetaxel, and / or cabazitaxel).